P radioactive β-emitting stents were used in coronary artery lesions with results showing inhibition of<unk>  in a dose-dependent manner. A 6-month follow up post-implantation of the radioactive stents showed little adverse side-effects in the patients. However, more recent studies have shown that patients have a late progression of in-stent<unk>  after 1 year of radioactive stent implantation, suggesting a delay in the development of<unk>  rather than a prevention or decline of the condition. Drug-eluting stents coated with anti-proliferative chemicals are used to counteract<unk>  after stents placement. Drug-eluting stents that release resveratrol and quercetin show promise with marked reduction in intimal<unk>  compared to bare, metal stents.
Neointimal hyperplasia
Intimal hyperplasia
Neovascularization
Endothelial activation
Hydrodilatation
Infibulation
Glomerulation
Angiomatosis